Joost DeJongh
YOU?
Author Swipe
View article: Defining preclinical efficacy with the DNAPK inhibitor AZD7648 in combination with olaparib: a minimal systems pharmacokinetic–pharmacodynamic model
Defining preclinical efficacy with the DNAPK inhibitor AZD7648 in combination with olaparib: a minimal systems pharmacokinetic–pharmacodynamic model Open
View article: Navigating the landscape of parameter identifiability methods: A workflow recommendation for model development
Navigating the landscape of parameter identifiability methods: A workflow recommendation for model development Open
In pharmacometric modeling, it is often important to know whether the data is sufficiently rich to identify the parameters of a proposed model. While it may be possible to assess this based on the results of a model fit, it is often diffic…